CHSN
Overvalued by 4614.3% based on the discounted cash flow analysis.
Market cap | $317.02 Million |
---|---|
Enterprise Value | $324.70 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $0 |
Beta | -2.46 |
Outstanding Shares | 12,408,457 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -874.73 |
---|---|
PEG | 221.9 |
Price to Sales | - |
Price to Book Ratio | 0.13 |
Enterprise Value to Revenue | 31.84 |
Enterprise Value to EBIT | -542.28 |
Enterprise Value to Net Income | 3575 |
Total Debt to Enterprise | 0.06 |
Debt to Equity | 1.07 |
No data
No data